Detalles de la búsqueda
1.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
N Engl J Med
; 387(1): 9-20, 2022 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665782
2.
Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer.
Breast Cancer Res Treat
; 205(1): 181-191, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279017
3.
A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.
Int J Cancer
; 153(8): 1501-1511, 2023 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37357950
4.
Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study.
Ann Surg Oncol
; 30(8): 4669-4677, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828929
5.
Short-term serial assessment of electronic patient-reported outcome for depression and anxiety in breast Cancer.
BMC Cancer
; 21(1): 1065, 2021 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587936
6.
Axillary Nodal Burden Assessed with Pretreatment Breast MRI Is Associated with Failed Sentinel Lymph Node Identification after Neoadjuvant Chemotherapy for Breast Cancer.
Radiology
; 295(2): 275-282, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125253
7.
Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy.
BMC Cancer
; 20(1): 1106, 2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33198673
8.
Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement.
Eur Radiol
; 30(9): 4785-4794, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314056
9.
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).
Br J Cancer
; 121(12): 985-990, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31690831
10.
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11).
Breast Cancer Res Treat
; 178(2): 367-377, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31407230
11.
Impact of Epidermal Growth Factor Receptor Mutation on Clinical Outcomes of Nintedanib Plus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer from the Korean Named Patient Program.
Oncology
; 96(1): 51-58, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30368503
12.
Overcoming Tamoxifen Resistance by Regulation of Del-1 in Breast Cancer.
Oncology
; 97(3): 180-188, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330520
13.
Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study.
BMC Cancer
; 19(1): 859, 2019 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31470821
14.
Efficacy of an RNA-based multigene assay with core needle biopsy samples for risk evaluation in hormone-positive early breast cancer.
BMC Cancer
; 19(1): 388, 2019 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023265
15.
Restaging the axilla after neo-adjuvant chemotherapy for breast cancer: Predictive factors for residual metastatic lymph node disease with negative imaging findings.
Breast J
; 25(2): 196-201, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30714256
16.
MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells.
Int J Mol Sci
; 20(24)2019 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31817673
17.
Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy for Guidance of Axillary Surgery in Breast Cancer Patients: Experience with Activated Charcoal.
Ann Surg Oncol
; 25(2): 494-500, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29134374
18.
ASO Visual Abstract: Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study.
Ann Surg Oncol
; 30(8): 4680-4681, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37225834
19.
Del-1 Expression as a Potential Biomarker in Triple-Negative Early Breast Cancer.
Oncology
; 94(4): 243-256, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29393238
20.
Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells.
Tumour Biol
; 39(6): 1010428317707374, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653903